Ng/BACE1 levels were elevated in both subjective cognitive decline and mild cognitive impairment compared to healthy controls [23] and can distinguish between depression and AD among patients with similar cognitive deficits, along with the classic AD biomarkers [24]. Here, BACE1 is linked to Alzheimer disease.